Early Infantile Epileptic Encephalopathy Gene Panel
Comprehensive Genetic Testing for Severe Infant Seizure Disorders
The Early Infantile Epileptic Encephalopathy Gene Panel represents a cutting-edge diagnostic tool in pediatric neurology and genetics. This specialized genetic test is designed to identify mutations responsible for severe seizure disorders that manifest in the first months of life. Early Infantile Epileptic Encephalopathy (EIEE) encompasses a group of devastating neurological conditions characterized by treatment-resistant seizures, developmental regression, and significant neurological impairment.
What This Advanced Genetic Panel Measures
Our comprehensive gene panel utilizes next-generation sequencing (NGS) technology to analyze multiple genes simultaneously associated with early-onset epileptic encephalopathies. The test specifically targets:
- Genes known to cause Ohtahara syndrome and other early infantile epileptic encephalopathies
- Mutations affecting ion channels, synaptic proteins, and metabolic pathways
- Both inherited and de novo genetic variations
- Copy number variations and specific point mutations
Who Should Consider This Genetic Testing
This specialized panel is recommended for infants and young children presenting with:
- Unexplained seizures beginning in the first 3 months of life
- Developmental regression following seizure onset
- Abnormal EEG patterns including burst-suppression
- Family history of similar neurological conditions
- Resistance to conventional anti-epileptic medications
- Multiple seizure types including tonic, myoclonic, or focal seizures
Significant Benefits of Early Genetic Diagnosis
Obtaining a precise genetic diagnosis through this comprehensive panel offers numerous advantages:
- Personalized Treatment Planning: Specific genetic findings can guide targeted therapeutic approaches
- Prognostic Information: Understanding the underlying genetic cause helps predict disease progression
- Family Planning Guidance: Identifies inheritance patterns for future family planning decisions
- Early Intervention: Enables prompt initiation of appropriate therapies and supportive care
- Research Participation: May qualify patients for clinical trials and emerging treatments
Understanding Your Test Results
Our comprehensive genetic counseling support helps families understand their results:
- Positive Result: Identifies a specific genetic mutation, providing clear diagnostic information
- Negative Result: Does not completely rule out genetic causes but may suggest alternative testing
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Unexpected Findings: May reveal additional genetic information relevant to patient care
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Early Infantile Epileptic Encephalopathy Gene Panel | $900 USD | $1200 USD |
Nationwide Testing Availability
We have convenient testing locations across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures accessible testing for families nationwide.
Take the Next Step Toward Answers
If your infant is experiencing unexplained seizures or developmental concerns, don’t wait to seek answers. Our Early Infantile Epileptic Encephalopathy Gene Panel provides comprehensive genetic insights that can transform your child’s care journey. Contact our genetic counselors today to discuss whether this test is appropriate for your situation.
Call or WhatsApp us at +1(267) 388-9828 to schedule your consultation and testing appointment. Our team of genetic specialists is ready to guide you through the testing process and help you understand the results.
Note: This test requires a doctor’s prescription for most cases. Prescription requirements may vary for surgical cases, pregnancy-related testing, or international travel purposes.

